LFVN (STOCKS)
Lifevantage Corporation Common Stock (Delaware)
$4.920000
-0.170000 (-3.34%)
Prev close: $5.090000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Steven R. Fife
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $63.33M
- Employees
- 238
- P/E (TTM)
- 8.22
- P/B (TTM)
- 1.91
- Dividend Yield
- 355.69%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q2)
|
$0.15 | $0.15 | -0.0030 | -1.96% |
|
Sep 2025 (Q1)
|
$0.18 | $0.19 | -0.0087 | -4.61% |
|
Jun 2025 (Q4)
|
$0.15 | $0.16 | -0.0081 | -5.12% |
|
Mar 2025 (Q3)
|
$0.26 | $0.17 | +0.0934 | +56.06% |
Financial Statements
| Revenues | $210.05M |
| Benefits Costs and Expenses | $200.76M |
| Cost Of Revenue | $44.65M |
| Costs And Expenses | $200.76M |
| Gross Profit | $165.40M |
| Nonoperating Income/Loss | $334.00K |
| Operating Expenses | $156.45M |
| Selling, General, and Administrative Expenses | $66.43M |
| Research and Development | $1.30M |
| Other Operating Expenses | $88.62M |
| Operating Income/Loss | $8.96M |
| Income/Loss From Continuing Operations After Tax | $7.86M |
| Income/Loss From Continuing Operations Before Tax | $9.29M |
| Income Tax Expense/Benefit | $1.43M |
| Income Tax Expense/Benefit, Deferred | $1.34M |
| Net Income/Loss | $7.86M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $7.86M |
| Net Income/Loss Available To Common Stockholders, Basic | $7.86M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.63 |
| Diluted Earnings Per Share | $0.60 |
| Basic Average Shares | 24,894,000 |
| Diluted Average Shares | 26,151,000 |
| Common Stock Dividends | $0.18 |
| Assets | $61.17M |
| Current Assets | $38.56M |
| Inventory | $18.98M |
| Other Current Assets | $19.58M |
| Noncurrent Assets | $22.61M |
| Fixed Assets | $6.43M |
| Intangible Assets | $3.32M |
| Other Non-current Assets | $12.87M |
| Liabilities | $28.18M |
| Current Liabilities | $19.01M |
| Accounts Payable | $4.89M |
| Other Current Liabilities | $14.12M |
| Noncurrent Liabilities | $9.17M |
| Equity | $32.99M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $32.99M |
| Liabilities And Equity | $61.17M |
| Net Cash Flow From Operating Activities | $3.75M |
| Net Cash Flow From Operating Activities, Continuing | $3.75M |
| Net Cash Flow From Investing Activities | -$5.80M |
| Net Cash Flow From Investing Activities, Continuing | -$5.80M |
| Net Cash Flow From Financing Activities | -$9.41M |
| Net Cash Flow From Financing Activities, Continuing | -$9.41M |
| Exchange Gains/Losses | $39.00K |
| Net Cash Flow | -$11.41M |
| Net Cash Flow, Continuing | -$11.45M |
| Comprehensive Income/Loss | $8.05M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $8.05M |
| Other Comprehensive Income/Loss | -$1.75M |